Cargando…

Clinical Impact of Cardiac Fibrosis on Arrhythmia Recurrence after Ablation in Adults with Congenital Heart Disease

Background. Adults with congenital heart disease (ACHD) are often affected by cardiac arrhythmias requiring catheter ablation. Catheter ablation in this setting represents the treatment of choice but is flawed by frequent recurrencies. Predictors of arrhythmia relapse have been identified, but the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Perna, Francesco, Telesca, Alessandro, Scacciavillani, Roberto, Narducci, Maria Lucia, Bencardino, Gianluigi, Pinnacchio, Gaetano, Spera, Francesco Raffaele, Sabarese, Rocco, Comerci, Gianluca, Pelargonio, Gemma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141040/
https://www.ncbi.nlm.nih.gov/pubmed/37103047
http://dx.doi.org/10.3390/jcdd10040168
_version_ 1785033297318903808
author Perna, Francesco
Telesca, Alessandro
Scacciavillani, Roberto
Narducci, Maria Lucia
Bencardino, Gianluigi
Pinnacchio, Gaetano
Spera, Francesco Raffaele
Sabarese, Rocco
Comerci, Gianluca
Pelargonio, Gemma
author_facet Perna, Francesco
Telesca, Alessandro
Scacciavillani, Roberto
Narducci, Maria Lucia
Bencardino, Gianluigi
Pinnacchio, Gaetano
Spera, Francesco Raffaele
Sabarese, Rocco
Comerci, Gianluca
Pelargonio, Gemma
author_sort Perna, Francesco
collection PubMed
description Background. Adults with congenital heart disease (ACHD) are often affected by cardiac arrhythmias requiring catheter ablation. Catheter ablation in this setting represents the treatment of choice but is flawed by frequent recurrencies. Predictors of arrhythmia relapse have been identified, but the role of cardiac fibrosis in this setting has not been investigated. The aim of this study was to determine the role of the extension of cardiac fibrosis, detected by electroanatomical mapping, in predicting arrhythmia recurrencies after ablation in ACHD. Materials and Methods. Consecutive patients with congenital heart disease and atrial or ventricular arrhythmias undergoing catheter ablation were enrolled. An electroanatomical bipolar voltage map was performed during sinus rhythm in each patient and bipolar scar was assessed according to the current literature data. During follow-up, arrhythmia recurrences were recorded. The relationship between the extent of myocardial fibrosis and arrhythmia recurrence was assessed. Results. Twenty patients underwent successful catheter ablation of atrial (14) or ventricular (6) arrhythmias, with no inducible arrhythmia at the end of the procedure. During a median follow-up period of 207 weeks (IQR 80 weeks), eight patients (40%; five atrial and three ventricular arrhythmias) had arrhythmia recurrence. Of the five patients undergoing a second ablation, four showed a new reentrant circuit, while one patient had a conduction gap across a previous ablation line. The extension of the bipolar scar area (HR 1.049, CI 1.011–1.089, p = 0.011) and the presence of a bipolar scar area >20 cm(2) (HR 6.101, CI 1.147–32.442, p = 0.034) were identified as predictors of arrhythmia relapse. Conclusion. The extension of the bipolar scar area and the presence of a bipolar scar area >20 cm(2) can predict arrhythmia relapse in ACHD undergoing catheter ablation of atrial and ventricular arrhythmias. Recurrent arrhythmias are often caused by circuits other than those previously ablated.
format Online
Article
Text
id pubmed-10141040
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101410402023-04-29 Clinical Impact of Cardiac Fibrosis on Arrhythmia Recurrence after Ablation in Adults with Congenital Heart Disease Perna, Francesco Telesca, Alessandro Scacciavillani, Roberto Narducci, Maria Lucia Bencardino, Gianluigi Pinnacchio, Gaetano Spera, Francesco Raffaele Sabarese, Rocco Comerci, Gianluca Pelargonio, Gemma J Cardiovasc Dev Dis Article Background. Adults with congenital heart disease (ACHD) are often affected by cardiac arrhythmias requiring catheter ablation. Catheter ablation in this setting represents the treatment of choice but is flawed by frequent recurrencies. Predictors of arrhythmia relapse have been identified, but the role of cardiac fibrosis in this setting has not been investigated. The aim of this study was to determine the role of the extension of cardiac fibrosis, detected by electroanatomical mapping, in predicting arrhythmia recurrencies after ablation in ACHD. Materials and Methods. Consecutive patients with congenital heart disease and atrial or ventricular arrhythmias undergoing catheter ablation were enrolled. An electroanatomical bipolar voltage map was performed during sinus rhythm in each patient and bipolar scar was assessed according to the current literature data. During follow-up, arrhythmia recurrences were recorded. The relationship between the extent of myocardial fibrosis and arrhythmia recurrence was assessed. Results. Twenty patients underwent successful catheter ablation of atrial (14) or ventricular (6) arrhythmias, with no inducible arrhythmia at the end of the procedure. During a median follow-up period of 207 weeks (IQR 80 weeks), eight patients (40%; five atrial and three ventricular arrhythmias) had arrhythmia recurrence. Of the five patients undergoing a second ablation, four showed a new reentrant circuit, while one patient had a conduction gap across a previous ablation line. The extension of the bipolar scar area (HR 1.049, CI 1.011–1.089, p = 0.011) and the presence of a bipolar scar area >20 cm(2) (HR 6.101, CI 1.147–32.442, p = 0.034) were identified as predictors of arrhythmia relapse. Conclusion. The extension of the bipolar scar area and the presence of a bipolar scar area >20 cm(2) can predict arrhythmia relapse in ACHD undergoing catheter ablation of atrial and ventricular arrhythmias. Recurrent arrhythmias are often caused by circuits other than those previously ablated. MDPI 2023-04-13 /pmc/articles/PMC10141040/ /pubmed/37103047 http://dx.doi.org/10.3390/jcdd10040168 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Perna, Francesco
Telesca, Alessandro
Scacciavillani, Roberto
Narducci, Maria Lucia
Bencardino, Gianluigi
Pinnacchio, Gaetano
Spera, Francesco Raffaele
Sabarese, Rocco
Comerci, Gianluca
Pelargonio, Gemma
Clinical Impact of Cardiac Fibrosis on Arrhythmia Recurrence after Ablation in Adults with Congenital Heart Disease
title Clinical Impact of Cardiac Fibrosis on Arrhythmia Recurrence after Ablation in Adults with Congenital Heart Disease
title_full Clinical Impact of Cardiac Fibrosis on Arrhythmia Recurrence after Ablation in Adults with Congenital Heart Disease
title_fullStr Clinical Impact of Cardiac Fibrosis on Arrhythmia Recurrence after Ablation in Adults with Congenital Heart Disease
title_full_unstemmed Clinical Impact of Cardiac Fibrosis on Arrhythmia Recurrence after Ablation in Adults with Congenital Heart Disease
title_short Clinical Impact of Cardiac Fibrosis on Arrhythmia Recurrence after Ablation in Adults with Congenital Heart Disease
title_sort clinical impact of cardiac fibrosis on arrhythmia recurrence after ablation in adults with congenital heart disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141040/
https://www.ncbi.nlm.nih.gov/pubmed/37103047
http://dx.doi.org/10.3390/jcdd10040168
work_keys_str_mv AT pernafrancesco clinicalimpactofcardiacfibrosisonarrhythmiarecurrenceafterablationinadultswithcongenitalheartdisease
AT telescaalessandro clinicalimpactofcardiacfibrosisonarrhythmiarecurrenceafterablationinadultswithcongenitalheartdisease
AT scacciavillaniroberto clinicalimpactofcardiacfibrosisonarrhythmiarecurrenceafterablationinadultswithcongenitalheartdisease
AT narduccimarialucia clinicalimpactofcardiacfibrosisonarrhythmiarecurrenceafterablationinadultswithcongenitalheartdisease
AT bencardinogianluigi clinicalimpactofcardiacfibrosisonarrhythmiarecurrenceafterablationinadultswithcongenitalheartdisease
AT pinnacchiogaetano clinicalimpactofcardiacfibrosisonarrhythmiarecurrenceafterablationinadultswithcongenitalheartdisease
AT sperafrancescoraffaele clinicalimpactofcardiacfibrosisonarrhythmiarecurrenceafterablationinadultswithcongenitalheartdisease
AT sabareserocco clinicalimpactofcardiacfibrosisonarrhythmiarecurrenceafterablationinadultswithcongenitalheartdisease
AT comercigianluca clinicalimpactofcardiacfibrosisonarrhythmiarecurrenceafterablationinadultswithcongenitalheartdisease
AT pelargoniogemma clinicalimpactofcardiacfibrosisonarrhythmiarecurrenceafterablationinadultswithcongenitalheartdisease